Which statement best describes how all clinical trial information should be treated?

Which statement best describes how all clinical trial information should be treated?

• A. All clinical trial information should be recorded, handled, and stored in a way that allows its accurate reporting interpretation and verification.
• B. All records must be de-identified and stored with no identifiers.
• C. Data should be recorded only in the patient's chart.
• D. Only data necessary for primary outcomes should be stored.

Answer: (A)

The essential idea is that every piece of clinical trial information must be recorded, handled, and stored so that the data remain accurate, complete, contemporaneous, and verifiable. This ensures that results can be reported correctly, interpreted reliably, and reconstructed for verification during audits or inspections. Data should have a clear link to source documents, be managed to protect participant confidentiality, and be accessible to authorized personnel for monitoring and regulatory review. De-identifying all records or storing only data for primary outcomes would hinder the ability to verify and fully assess the trial’s integrity.

The essential idea is that every piece of clinical trial information must be recorded, handled, and stored so that the data remain accurate, complete, contemporaneous, and verifiable. This ensures that results can be reported correctly, interpreted reliably, and reconstructed for verification during audits or inspections. Data should have a clear link to source documents, be managed to protect participant confidentiality, and be accessible to authorized personnel for monitoring and regulatory review. De-identifying all records or storing only data for primary outcomes would hinder the ability to verify and fully assess the trial’s integrity.